Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures.
Tricyclic antidepressants (imipramine and desipramine) gave rise to an important decrease of sphingomyelinase activity in murine neuroblastoma and human fibroblast cell cultures. It occurred within 1 to 2 hours at a final concentration of 1 or 2 X 10(-5) M in cell culture medium. Other lysosomal enzymes such as acid lipase, arylsulfatases A and B and hexosaminidases were not modified. Low level of sphingomyelinase activity may be related to the amphiphilic characteristics of the drugs: iminodibenzyle which has the same tricyclic core but is devoid of the side chain necessary for amphiphilic properties had no effect. As iminodibenzyle has no therapeutic action, amphiphilic may be requisite to antidepressant properties of tricyclic drugs.
D000818:Animals; D002478:Cells, Cultured; D003891:Desipramine / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology*; D051379:Mice; D009447:Neuroblastoma / Q000201:enzymology*; D010727:Phosphoric Diester Hydrolases / Q000172:deficiency*; D012867:Skin; D013108:Sphingomyelin Phosphodiesterase / Q000172:deficiency* / Q000378:metabolism
D010727:Phosphoric Diester Hydrolases; D013108:Sphingomyelin Phosphodiesterase; D007099:Imipramine; D003891:Desipramine